The ımpact of the novel tumor marker ındex (TMI) on survival and prognosis in metastatic gastric cancer
American Journal of Cancer Research · 2026 · 16 (10) · 4481-4493
DOI: 10.62347/jgid2940 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Cancer Research, 2026. Verfasst von Ozge Demirkiran und 11 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Demirkiran, O., Demir, B., Balcik, O. Y., Avci, T., Erdogan, A. P., Ekinci, F., Saray, S., Acar, O., Demir, N., Aytac, A., Beypinar, I., & Oktay, E. (2026). The ımpact of the novel tumor marker ındex (TMI) on survival and prognosis in metastatic gastric cancer. American Journal of Cancer Research, 16(10), 4481-4493. https://doi.org/10.62347/jgid2940
Vancouver
Demirkiran O, Demir B, Balcik OY, Avci T, Erdogan AP, Ekinci F, et al. The ımpact of the novel tumor marker ındex (TMI) on survival and prognosis in metastatic gastric cancer. American Journal of Cancer Research. 2026;16(10):4481-4493. doi:10.62347/jgid2940
BibTeX
@article{Demirkiran2026,
author = {Demirkiran, Ozge and Demir, Bilgin and Balcik, Onur Y and Avci, Tugay and Erdogan, Atike P and Ekinci, Ferhat and Saray, Seray and Acar, Omer and Demir, Nazan and Aytac, Ali and Beypinar, Ismail and Oktay, Esin},
title = {The ımpact of the novel tumor marker ındex (TMI) on survival and prognosis in metastatic gastric cancer},
journal = {American Journal of Cancer Research},
year = {2026},
volume = {16},
number = {10},
pages = {4481--4493},
doi = {10.62347/jgid2940}
}
EUVIMED